GSK's David Stout
David Stout, GlaxoSmithKline's former president of pharmaceutical operations, left the company in December 2007 after he was passed over for the position of CEO. He turned down a $4 million incentive package and a spot on the company's board.
Related Articles:
Musical chairs at GSK leaves Stout out
GSK runners-up get $4M, board seat
GSK CEO also-rans may get on board
At GSK, a public race for the top spot
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
